Quantcast

Latest Celldex Therapeutics Stories

2008-11-12 12:00:31

Celldex Therapeutics, an integrated biopharmaceutical company, has signed an exclusive patent and know-how license agreement with the University of Southampton, UK, to develop human antibodies towards CD27, a potentially important target for immunotherapy of various cancers.

2008-11-04 03:00:05

Celldex Therapeutics, an integrated biopharmaceutical company, has announced initial results from multi-center Phase I clinical trials of its cancer vaccine candidate, CDX-1307, combined with GM-CSF.

2008-10-03 09:00:38

Celldex Therapeutics, an integrated biopharmaceutical company, has received a milestone payment of $10 million from an affiliate of Paul Capital Healthcare. The payment was triggered by the market launch of Rotarix in the US. Rotarix is marketed worldwide by GlaxoSmithKline.


Word of the Day
edulcoration
  • The act of sweetening by admixture of some saccharine substance.
The word 'edulcoration' comes from a Latin word meaning 'making sweet'.